Related Experiment Videos
[Antibiotic prophylaxis using cefuroxime in bile duct endoscopy]
1II. Medizinische Klinik und Poliklinik der Technischen Universität, München.
Deutsche Medizinische Wochenschrift (1946)
|February 23, 1996
Summary
A single prophylactic dose of cefuroxim before therapeutic endoscopy showed a trend towards reducing bloodstream infections, though not statistically significant. Further research is recommended for optimal antibiotic prophylaxis in endoscopic procedures.
Area of Science:
- Gastroenterology
- Infectious Diseases
- Pharmacology
Background:
- Routine antibiotic prophylaxis is not standard practice before therapeutic endoscopy.
- Assessing the effectiveness of prophylactic antibiotics is crucial for patient safety.
Observation:
- A prospective study involved 99 patients undergoing endoscopic retrograde cholangiopancreatography (ERCP) or percutaneous transhepatic cholangiography with drainage (PTCD).
- Group A (n=49) received cefuroxim 30 minutes pre-procedure; Group B (n=50) did not receive antibiotics.
- Blood and bile cultures were analyzed for bacterial presence and sensitivity.
Findings:
- Bacteraemia occurred in 6.1% of the cefuroxim group versus 16% in the control group (not statistically significant).
- Septicaemia rates were 6.1% and 10%, respectively (not statistically significant).
- Escherichia coli was the most common microorganism; in vitro cefuroxim sensitivity was 53.3% in blood and 53.4% in bile.
Implications:
- While not statistically significant, cefuroxim prophylaxis may offer clinical benefits in reducing post-endoscopy infections.
- Higher dosages or antibiotic combinations may be necessary to improve efficacy.
- Further studies are warranted to establish optimal antibiotic strategies for therapeutic endoscopy.